Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Get Adobe Flash player

Warning issued over caffeine inhaler Add to ...

Food and Drug Administration officials have issued a warning letter to the makers of the inhalable caffeine product AeroShot, saying they have questions about its safety and concerns about how children and adolescents may use it.



In the know

More from The Globe and Mail

Most popular stories